Serum CEACAM1 correlates with disease progression and survival in malignant melanoma patients
- Sapoznik Sivan
- , Faranesh Suzan
- , Ortenberg Rona
- , Hamburger Tamar
- , Barak Vivian
- , Peretz Tamar
- , Schachter Jacob
- , Markel Gal*
- , Lotem Michal
*Corresponding author for this work
- Sheba Medical Center at Tel Hashomer
- Hadassah University Medical Centre
- Tel Aviv University
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations